\BOOKMARK [0][-]{section*.2}{SEIR-C: An epidemic model that includes contact tracing}{}% 2
\BOOKMARK [1][-]{section*.1}{Abstract}{section*.2}% 1
\BOOKMARK [1][-]{section*.3}{Introduction to SEIR}{section*.2}% 3
\BOOKMARK [1][-]{section*.4}{SEIR with testing \(SEIR-T\)}{section*.2}% 4
\BOOKMARK [1][-]{section*.5}{SEIR with contact tracing \(SEIR-C\)}{section*.2}% 5
\BOOKMARK [1][-]{section*.6}{Description of model}{section*.2}% 6
\BOOKMARK [1][-]{section*.7}{Susceptible}{section*.2}% 7
\BOOKMARK [1][-]{section*.8}{Exposure}{section*.2}% 8
\BOOKMARK [1][-]{section*.9}{Infectious}{section*.2}% 9
\BOOKMARK [2][-]{section*.10}{Individuals who are infectious and display symptoms}{section*.9}% 10
\BOOKMARK [2][-]{section*.11}{Asymptomatic}{section*.9}% 11
\BOOKMARK [1][-]{section*.12}{Outcomes}{section*.2}% 12
\BOOKMARK [2][-]{section*.13}{Asymptomatic}{section*.12}% 13
\BOOKMARK [3][-]{section*.14}{Mild}{section*.13}% 14
\BOOKMARK [2][-]{section*.15}{Severe}{section*.12}% 15
\BOOKMARK [3][-]{section*.16}{Hospitalized}{section*.15}% 16
\BOOKMARK [2][-]{section*.17}{Deaths}{section*.12}% 17
\BOOKMARK [2][-]{section*.18}{Recovery}{section*.12}% 18
